Vivo Opportunity, LLC's Form 4 filing
IO Biotech, Inc. (IOBT) · filed Aug 10, 2023
- Accession no.
- 0001213900-23-065297
- Filed
- Aug 10, 2023, 9:03 AM ET
- Trade date
- Aug 9, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $6.00M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vivo Opportunity, LLCCIK 0001728970 | 10% Owner |
| Vivo Capital Fund IX, L.P.CIK 0001750117 | 10% Owner |
| Vivo Capital IX, LLCCIK 0001750698 | 10% Owner |
| Vivo Opportunity Fund Holdings, L.P.CIK 0001930214 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +3,157,894 | $1.90 | +$5,999,998.6 | 3,157,894 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +3,157,894 | $0.125 | +$394,736.75 | 3,157,894 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.